PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

Core Points - PAVmed Inc. will host a business update conference call and webcast on November 13, 2025, at 8:30 AM ET, where the CEO will discuss the company's operations and growth strategy, and the CFO will present the third quarter 2025 financial results [1][2]. Company Overview - PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics, focuses on cancer prevention with products like the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device, which are designed for early detection of esophageal precancer [4]. - Another subsidiary, Veris Health Inc., is dedicated to personalized cancer care through remote patient monitoring using implantable biologic sensors and connected external devices. Veris is also developing an implantable physiological monitor to work alongside chemotherapy ports [4].